KoBioLabs is involved in the development of microbiome therapeutics within the biopharmaceutical industry
KoBioLabs is involved in the development of microbiome therapeutics within the biopharmaceutical industry. The company specializes in treatments that target immunology, metabolism, and immuno-oncology, utilizing its AI-driven multi-omics platform, Smartiome.